Fundraising Fox

Kostas Kaloulis

Investor

Venture Partner at +ND Capital

Lausanne

About

Kostas joined +ND Capital's Lausanne office in 2018 and is CEO of EVIR Therapeutics, having spun out companies from EPFL and the University of Bern. He holds a PhD in Molecular Embryology.

Contact· self-published, not guessed

Experience

  1. Altitude Investment ManagementPartnercurrent2017 — presentGreater New York City Area
  2. Drivetrain, LLCFounding Partnercurrent2013 — presentNew York NY
  3. Board ServiceBoard Experiencecurrent1999 — present
  4. Longacre Fund ManagementPrincipal & Co-Founder1999 — 2012NY, NY & London, Uk
  5. The Bear Stearns Companies, IncVice President, High Yield Department1996 — 1998New York, NY
  6. Credit Research & TradingHead Trader, Claims Trades1995 — 1996Greenwich, CT
  7. Pryor, Cashman et. al.Associate, Bankruptcy Department1991 — 1994New York, NY
  8. Angel & FrankelAssociate, Bankruptcy Department1988 — 1991New York, NY

Skills & more

Private Equity9Asset Managment1Hedge Funds16Alternative Investments7Equities5Venture Capital2Investments8Due Diligence2Asset Management4Capital Markets2Valuation2Investment Banking7
+12 moreBoard of DirectorsBoard Advisory ServicesCorporate LawCreditor RepresentationFiduciary ServicesMarketingCredit AnalysisManagementStrategyStrategic PlanningAlternative Dispute ResolutionComplex Financial Restructuring

From Kostas's professional profile.

Colleagues at +ND Capital

Frequently asked questions

Who is Kostas Kaloulis?
Kostas joined +ND Capital's Lausanne office in 2018 and is CEO of EVIR Therapeutics, having spun out companies from EPFL and the University of Bern. He holds a PhD in Molecular Embryology.
Where does Kostas Kaloulis work?
Kostas Kaloulis is Venture Partner at +ND Capital.
Where did Kostas Kaloulis go to school?
Kostas Kaloulis studied at American University (Bachelor's Degree, Political Science); St. John's University School of Law (Juris Doctor (J.D.)).

Same school

Shared employers